These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 7853521

  • 1. Syncytium-inducing (SI) phenotype suppression at seroconversion after intramuscular inoculation of a non-syncytium-inducing/SI phenotypically mixed human immunodeficiency virus population.
    Cornelissen M, Mulder-Kampinga G, Veenstra J, Zorgdrager F, Kuiken C, Hartman S, Dekker J, van der Hoek L, Sol C, Coutinho R.
    J Virol; 1995 Mar; 69(3):1810-8. PubMed ID: 7853521
    [Abstract] [Full Text] [Related]

  • 2. Syncytium-inducing and non-syncytium-inducing capacity of human immunodeficiency virus type 1 subtypes other than B: phenotypic and genotypic characteristics. WHO Network for HIV Isolation and Characterization.
    De Wolf F, Hogervorst E, Goudsmit J, Fenyö EM, Rübsamen-Waigmann H, Holmes H, Galvao-Castro B, Karita E, Wasi C, Sempala SD.
    AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1387-400. PubMed ID: 7888192
    [Abstract] [Full Text] [Related]

  • 3. Syncytium induction in primary CD4+ T-cell lines from normal donors by human immunodeficiency virus type 1 isolates with non-syncytium-inducing genotype and phenotype in MT-2 cells.
    Todd BJ, Kedar P, Pope JH.
    J Virol; 1995 Nov; 69(11):7099-105. PubMed ID: 7474129
    [Abstract] [Full Text] [Related]

  • 4. HIV type 1 V3 variation dynamics in vivo: long-term persistence of non-syncytium-inducing genotypes and transient presence of syncytium-inducing genotypes during the course of progressive AIDS.
    Ida S, Gatanaga H, Shioda T, Nagai Y, Kobayashi N, Shimada K, Kimura S, Iwamoto A, Oka S.
    AIDS Res Hum Retroviruses; 1997 Dec 10; 13(18):1597-609. PubMed ID: 9430252
    [Abstract] [Full Text] [Related]

  • 5. Maintenance of syncytium-inducing phenotype of HIV type 1 is associated with positively charged residues in the HIV type 1 gp120 V2 domain without fixed positions, elongation, or relocated N-linked glycosylation sites.
    Cornelissen M, Hogervorst E, Zorgdrager F, Hartman S, Goudsmit J.
    AIDS Res Hum Retroviruses; 1995 Oct 10; 11(10):1169-75. PubMed ID: 8573372
    [Abstract] [Full Text] [Related]

  • 6. Evolutionary variants of the human immunodeficiency virus type 1 V3 region characterized by using a heteroduplex tracking assay.
    Nelson JA, Fiscus SA, Swanstrom R.
    J Virol; 1997 Nov 10; 71(11):8750-8. PubMed ID: 9343234
    [Abstract] [Full Text] [Related]

  • 7. Relationship of HIV-1 envelope V2 and V3 sequences of the primary isolates to the viral phenotype.
    Yoshimura K, Matsushita S, Hayashi A, Takatsuki K.
    Microbiol Immunol; 1996 Nov 10; 40(4):277-87. PubMed ID: 8709863
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Human immunodeficiency virus type 1 populations in blood and semen.
    Delwart EL, Mullins JI, Gupta P, Learn GH, Holodniy M, Katzenstein D, Walker BD, Singh MK.
    J Virol; 1998 Jan 10; 72(1):617-23. PubMed ID: 9420266
    [Abstract] [Full Text] [Related]

  • 11. A group of V3 sequences from human immunodeficiency virus type 1 subtype E non-syncytium-inducing, CCR5-using variants are resistant to positive selection pressure.
    Shiino T, Kato K, Kodaka N, Miyakuni T, Takebe Y, Sato H.
    J Virol; 2000 Feb 10; 74(3):1069-78. PubMed ID: 10627516
    [Abstract] [Full Text] [Related]

  • 12. HIV-1 subtype C syncytium- and non-syncytium-inducing phenotypes and coreceptor usage among Ethiopian patients with AIDS.
    Abebe A, Demissie D, Goudsmit J, Brouwer M, Kuiken CL, Pollakis G, Schuitemaker H, Fontanet AL, Rinke de Wit TF.
    AIDS; 1999 Jul 30; 13(11):1305-11. PubMed ID: 10449282
    [Abstract] [Full Text] [Related]

  • 13. Insertion of primary syncytium-inducing (SI) and non-SI envelope V3 loops in human immunodeficiency virus type 1 (HIV-1) LAI reduces neutralization sensitivity to autologous, but not heterologous, HIV-1 antibodies.
    Hogervorst E, de Jong J, van Wijk A, Bakker M, Valk M, Nara P, Goudsmit J.
    J Virol; 1995 Oct 30; 69(10):6342-51. PubMed ID: 7666535
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. V3 loop sequence analysis of seven HIV type 1 group O isolates phenotyped in peripheral blood mononuclear cells and MT-2 cells.
    De Jong J, Simon F, Van der Groen G, Baan E, Saragosti S, Brun-Vézinet F, Goudsmit J.
    AIDS Res Hum Retroviruses; 1996 Nov 01; 12(16):1503-7. PubMed ID: 8911575
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Simple determination of human immunodeficiency virus type 1 syncytium-inducing V3 genotype by PCR.
    Fouchier RA, Brouwer M, Broersen SM, Schuitemaker H.
    J Clin Microbiol; 1995 Apr 01; 33(4):906-11. PubMed ID: 7790458
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Primary subtype C HIV-1 infection in Harare, Zimbabwe.
    Tien PC, Chiu T, Latif A, Ray S, Batra M, Contag CH, Zejena L, Mbizvo M, Delwart EL, Mullins JI, Katzenstein DA.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Feb 01; 20(2):147-53. PubMed ID: 10048901
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.